Last 12 months
Inside the activity.
0 purchase rows · 3 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 17, 2018 Filed Sep 19, 2018 22:26 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 37,500 | $2.11 | $79,125.00 |
DisclosureSEC source: 0001179110-18-011567 · edgar.xml · nonDerivative · entry 3 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:26 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
SaleCommon Stock | 115,500 | $3.50 | $404,250.00 |
DisclosureSEC source: 0001179110-18-011567 · edgar.xml · nonDerivative · entry 2 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018. Read SEC document |
| September 17, 2018 Filed Sep 19, 2018 22:26 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 115,500 | $2.54 | $293,370.00 |
DisclosureSEC source: 0001179110-18-011567 · edgar.xml · nonDerivative · entry 1 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2018 Filed Sep 12, 2018 23:48 UTC |
Mayer Eldon C. IIIEVP & Chief Commercial Officer
|
PurchaseCommon Stock | 50,000 | $3.23 | $161,340.00 |
DisclosureSEC source: 0001179110-18-011343 · edgar.xml · nonDerivative · entry 2 Mayer Eldon C. III · CIK 0001686952 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,000 F2 · price: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transaction ranging from $3.19 to $3.27. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each separate price. Read SEC document |
| September 10, 2018 Filed Sep 12, 2018 23:48 UTC |
Mayer Eldon C. IIIEVP & Chief Commercial Officer
|
PurchaseCommon Stock | 50,000 | $3.28 | $164,210.00 |
DisclosureSEC source: 0001179110-18-011343 · edgar.xml · nonDerivative · entry 1 Mayer Eldon C. III · CIK 0001686952 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,000 F1 · price: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transaction ranging from $3.26 to $3.31. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each separate price. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 23:02 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
Exercise / conversionEmploye Stock Option (right to buy) · Derivative | 16,500 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001179110-18-011179 · edgar.xml · derivative · entry 3 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 383,500 Underlying: Common Stock · 16,500 shares Expires 2026-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: One fourth (1/4th) of the option vests one (1) year from March 7, 2016 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 23:02 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
SaleCommon Stock | 16,500 | $3.51 | $57,860.55 |
DisclosureSEC source: 0001179110-18-011179 · edgar.xml · nonDerivative · entry 2 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018. F2 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions ranging from $3.50 to $3.53. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission full information regarding the shares sold at each such separate price. Read SEC document |
| September 04, 2018 Filed Sep 6, 2018 23:02 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
Exercise / conversionCommon Stock | 16,500 | $2.54 | $41,910.00 |
DisclosureSEC source: 0001179110-18-011179 · edgar.xml · nonDerivative · entry 1 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 23, 2018 Filed Aug 27, 2018 23:49 UTC |
Mayer Eldon C. IIIEVP & Chief Commercial Officer
|
PurchaseCommon Stock | 100,000 | $2.82 | $282,320.00 |
DisclosureSEC source: 0001179110-18-010936 · edgar.xml · nonDerivative · entry 1 Mayer Eldon C. III · CIK 0001686952 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 F1 · price: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions ranging from $2.78 to $2.86 Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each such separate price. F2 · balance_after: Includes 15,000 shares that were purchased by the Reporting Person under the Issuer's Employee Stock Purchase Plan, in increments of 5,000 shares, on June 30, 2017, December 29, 2017 and June 29, 2018. Read SEC document |
| August 17, 2018 Filed Aug 21, 2018 23:12 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
PurchaseCommon Stock | 114,000 | $2.63 | $300,002.40 |
DisclosureSEC source: 0001179110-18-010749 · edgar.xml · nonDerivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,519 F1 · price: The price reported in Column 4 is the weighted average price. These shares were purchased in multiple transactions ranging from $2.61 to $2.64. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares purchased at each such separate price. F2 · balance_after: Includes 2,502 shares that were purchased by the Reporting Person on June 29, 2018 under the Issuer's Employee Stock Purchase Plan. Read SEC document |
| August 14, 2018 Filed Aug 16, 2018 22:16 UTC |
Cabatuan NelsonPrincipal Accounting Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $2.76 | $0.00 |
DisclosureSEC source: 0001179110-18-010636 · edgar.xml · derivative · entry 1 Cabatuan Nelson · CIK 0001725908 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-08-14 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over forty-eight (48) months from the vesting commencement date of August 14, 2018. Read SEC document |
| July 02, 2018 Filed Jul 5, 2018 22:59 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
SaleCommon Stock | 5,000 | $2.79 | $13,932.00 |
DisclosureSEC source: 0001179110-18-009506 · edgar.xml · nonDerivative · entry 1 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26,2018. F2 · shares: The Reporting Person purchased these shares on June 29, 2018 under the Issuer's Employee Stock Purchase Plan. F3 · price: The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions ranging from $2.76 to $2.80. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each such separate price. Read SEC document |
| June 04, 2018 Filed Jun 6, 2018 23:59 UTC |
Schorno Dean LEVP &Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 167,500 | $0.00 Strike: $3.44 | $0.00 |
DisclosureSEC source: 0001179110-18-008176 · edgar.xml · derivative · entry 1 Schorno Dean L · CIK 0001509688 · EVP &Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 167,500 Underlying: Common Stock · 167,500 shares Expires 2028-06-04 F1 · derivative.exercise_date: One fourth (1/4th) of the option vests one year from June 4, 2018 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months. Read SEC document |
| May 17, 2018 Filed May 19, 2018 01:36 UTC |
Kotzin Brian L.Director
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001179110-18-007153 · edgar.xml · derivative · entry 1 Kotzin Brian L. · CIK 0001715332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 17, 2018 Filed May 19, 2018 01:37 UTC |
RINGROSE PETER SDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001179110-18-007154 · edgar.xml · derivative · entry 1 RINGROSE PETER S · CIK 0001199298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 17, 2018 Filed May 19, 2018 01:35 UTC |
MOOS WALTER HDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001179110-18-007152 · edgar.xml · derivative · entry 1 MOOS WALTER H · CIK 0001190272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 17, 2018 Filed May 19, 2018 01:31 UTC |
LYONS GARY ADirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001179110-18-007151 · edgar.xml · derivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) years from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 17, 2018 Filed May 19, 2018 01:29 UTC |
LAPOINTE ANTHONY GREGGDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001179110-18-007150 · edgar.xml · derivative · entry 1 LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 17, 2018 Filed May 19, 2018 01:28 UTC |
Katkin KeithDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001179110-18-007149 · edgar.xml · derivative · entry 1 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 17, 2018 Filed May 19, 2018 01:27 UTC |
Goodwin Bradford SDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $3.98 | $0.00 |
DisclosureSEC source: 0001179110-18-007148 · edgar.xml · derivative · entry 1 Goodwin Bradford S · CIK 0001293633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-05-17 F1 · derivative.exercise_date: The shares shall vest monthly over one (1) year from the date of grant subject to the reporting person's continuous service on the Company's Board of Directors. Read SEC document |
| May 09, 2018 Filed May 11, 2018 23:51 UTC |
Lasaga JosephVP Bus. Dev.& Alliance Mgmt.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-18-006682 · edgar.xml · derivative · entry 1 Lasaga Joseph · CIK 0001686916 · VP Bus. Dev.& Alliance Mgmt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: On February 2, 2017 the reporting person was granted an option to purchase 25,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option. Read SEC document |
| May 09, 2018 Filed May 11, 2018 23:47 UTC |
Mayer Eldon C. IIIEVP & Chief Commercial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-18-006680 · edgar.xml · derivative · entry 1 Mayer Eldon C. III · CIK 0001686952 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: On February 2, 2017 the reporting person was granted an option to purchase 50,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option. Read SEC document |
| May 09, 2018 Filed May 11, 2018 23:50 UTC |
Masuda EstebanSr. VP Research
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-18-006681 · edgar.xml · derivative · entry 1 Masuda Esteban · CIK 0001686849 · Sr. VP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: On February 2, 2017 the reporting person was granted an option to purchase 50,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option. Read SEC document |
| May 09, 2018 Filed May 11, 2018 23:41 UTC |
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-18-006679 · edgar.xml · derivative · entry 1 VANCE DOLLY · CIK 0001237676 · EVP Corp. Affairs, G.C., Sect. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: On February 2, 2017 the reporting person was granted an option to purchase 150,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option. Read SEC document |
| May 09, 2018 Filed May 11, 2018 23:29 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 450,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-18-006677 · edgar.xml · derivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: On February 2, 2017 the reporting person was granted an option to purchase 450,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option. Read SEC document |
| May 09, 2018 Filed May 11, 2018 23:33 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.11 | $0.00 |
DisclosureSEC source: 0001179110-18-006678 · edgar.xml · derivative · entry 1 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2027-02-02 F1 · derivative.exercise_date: On February 2, 2017 the reporting person was granted an option to purchase 150,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option. Read SEC document |
| April 20, 2018 Filed Apr 25, 2018 01:06 UTC |
Duliege Anne-MarieEVP & Chief Medical Officer
|
SaleCommon Stock | 5,000 | $4.11 | $20,550.00 |
DisclosureSEC source: 0001179110-18-005850 · edgar.xml · nonDerivative · entry 1 Duliege Anne-Marie · CIK 0001419579 · EVP & Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 26, 2018. F2 · shares: The Reporting Person purchased these shares on December 29, 2017 under the Employee Stock Purchase Plan. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 22:18 UTC |
Markel StacyEVP Human Resources
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $3.94 | $0.00 |
DisclosureSEC source: 0001179110-18-004818 · edgar.xml · derivative · entry 1 Markel Stacy · CIK 0001734780 · EVP Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2028-03-21 F1 · derivative.exercise_date: One fourth (1/4th) of the option vests one year from March 19, 2018 and thereafter the balance of the option vests in equal monthly installments over the next thirty-six (36) months. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 23:38 UTC |
Lasaga JosephVP Bus. Dev.& Alliance Mgmt.
|
GrantEmployee Stock Option (right to buy) · Derivative | 87,500 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-18-001145 · edgar.xml · derivative · entry 1 Lasaga Joseph · CIK 0001686916 · VP Bus. Dev.& Alliance Mgmt. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,500 Underlying: Common Stock · 87,500 shares Expires 2028-01-24 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 23:44 UTC |
Cabatuan NelsonPrincipal Accounting Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 24,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-18-001146 · edgar.xml · derivative · entry 1 Cabatuan Nelson · CIK 0001725908 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 23:35 UTC |
Masuda EstebanSr. VP Research
|
GrantEmployee Stock Option (right to buy) · Derivative | 125,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-18-001144 · edgar.xml · derivative · entry 1 Masuda Esteban · CIK 0001686849 · Sr. VP Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 23:33 UTC |
Mayer Eldon C. IIIEVP & Chief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-18-001143 · edgar.xml · derivative · entry 1 Mayer Eldon C. III · CIK 0001686952 · EVP & Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 23:30 UTC |
Duliege Anne-MarieChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-18-001142 · edgar.xml · derivative · entry 1 Duliege Anne-Marie · CIK 0001419579 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 23:27 UTC |
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.
|
GrantEmployee Stock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-18-001141 · edgar.xml · derivative · entry 1 VANCE DOLLY · CIK 0001237676 · EVP Corp. Affairs, G.C., Sect. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018. Read SEC document |
| January 24, 2018 Filed Jan 26, 2018 23:23 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (right to buy) · Derivative | 475,000 | $0.00 Strike: $4.49 | $0.00 |
DisclosureSEC source: 0001179110-18-001140 · edgar.xml · derivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,000 Underlying: Common Stock · 475,000 shares Expires 2028-01-24 F1 · derivative.exercise_date: The shares of common stock subject to the option vest in equal monthly installments over four (4) years from the vesting commencement date of January 1, 2018. Read SEC document |
| November 03, 2017 Filed Nov 8, 2017 02:07 UTC |
Maynard Ryan DEVP & CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $2.14 | $0.00 |
DisclosureSEC source: 0001179110-17-013850 · edgar.xml · derivative · entry 3 Maynard Ryan D · CIK 0001363984 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 100,000 shares Expires 2025-01-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested monthly over two years from January 1, 2015. Read SEC document |
| November 03, 2017 Filed Nov 8, 2017 02:07 UTC |
Maynard Ryan DEVP & CFO
|
SaleCommon Stock | 100,000 | $3.90 | $390,000.00 |
DisclosureSEC source: 0001179110-17-013850 · edgar.xml · nonDerivative · entry 2 Maynard Ryan D · CIK 0001363984 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 8, 2017. Read SEC document |
| November 03, 2017 Filed Nov 8, 2017 02:07 UTC |
Maynard Ryan DEVP & CFO
|
Exercise / conversionCommon Stock | 100,000 | $2.14 | $214,000.00 |
DisclosureSEC source: 0001179110-17-013850 · edgar.xml · nonDerivative · entry 1 Maynard Ryan D · CIK 0001363984 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 23:31 UTC |
LAPOINTE ANTHONY GREGGDirector
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $3.80 | $0.00 |
DisclosureSEC source: 0001179110-17-013684 · edgar.xml · derivative · entry 1 LAPOINTE ANTHONY GREGG · CIK 0001331860 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2027-10-31 F1 · derivative.exercise_date: The Option shall vest in equal monthly installments over the shorter of three years from the date of grant or the period beginning on the date the director is appointed to the Board and ending on the date of the annual meeting at which the director is first considered for election by the stockholders, provided that the non-employee director continues to provide services. Read SEC document |
| August 21, 2017 Filed Aug 24, 2017 00:26 UTC |
Kotzin Brian L.Director
|
GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001179110-17-011797 · edgar.xml · derivative · entry 1 Kotzin Brian L. · CIK 0001715332 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2027-08-21 F1 · derivative.exercise_date: The Option shall vest in equal monthly installments over the shorter of three years from the date of grant or the period beginning on the date the director is appointed to the Board and ending on the date of the annual meeting at which the director is first considered for election by the stockholders, provided that the non-employee director continues to provide services. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 21:39 UTC |
Duliege Anne-MarieChief Medical Officer
|
SaleCommon Stock | 5,000 | $2.69 | $13,427.00 |
DisclosureSEC source: 0001179110-17-010231 · edgar.xml · nonDerivative · entry 1 Duliege Anne-Marie · CIK 0001419579 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 10, 2016. F2 · shares: The Reporting Person purchased these shares on 6/30/17 under the Employee Stock Purchase Plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.75, inclusive. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the Securities and Exchange Commission, full information regarding the shares sold at each separate price within the range set forth in footnote three (3) of this Form 4. Read SEC document |
| May 12, 2017 Filed May 12, 2017 22:05 UTC |
RINGROSE PETER SDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001179110-17-007134 · edgar.xml · derivative · entry 1 RINGROSE PETER S · CIK 0001199298 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-05-12 F1 · derivative.exercise_date: The shares vest monthly over twelve (12) months from the date of grant. Read SEC document |
| May 12, 2017 Filed May 12, 2017 22:02 UTC |
MOOS WALTER HDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001179110-17-007133 · edgar.xml · derivative · entry 1 MOOS WALTER H · CIK 0001190272 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-05-12 F1 · derivative.exercise_date: The shares vest monthly over twelve (12) months from the date of grant. Read SEC document |
| May 12, 2017 Filed May 12, 2017 22:01 UTC |
Katkin KeithDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001179110-17-007132 · edgar.xml · derivative · entry 1 Katkin Keith · CIK 0001314596 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-05-12 F1 · derivative.exercise_date: The shares vest monthly over twelve (12) months from the date of grant. Read SEC document |
| May 12, 2017 Filed May 12, 2017 21:59 UTC |
Goodwin Bradford SDirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001179110-17-007130 · edgar.xml · derivative · entry 1 Goodwin Bradford S · CIK 0001293633 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-05-12 F1 · derivative.exercise_date: The shares vest monthly over twelve (12) months from the date of grant. Read SEC document |
| May 12, 2017 Filed May 12, 2017 21:58 UTC |
LYONS GARY ADirector
|
GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.61 | $0.00 |
DisclosureSEC source: 0001179110-17-007129 · edgar.xml · derivative · entry 1 LYONS GARY A · CIK 0001123343 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2027-05-12 F1 · derivative.exercise_date: The shares vest monthly over twelve (12) months from the date of grant. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:55 UTC |
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001179110-17-006154 · edgar.xml · derivative · entry 2 VANCE DOLLY · CIK 0001237676 · EVP Corp. Affairs, G.C., Sect. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2026-01-26 F2 · derivative.exercise_date: On January 26, 2016 the reporting person was granted an option to purchase 150,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:55 UTC |
VANCE DOLLYEVP Corp. Affairs, G.C., Sect.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 62,500 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001179110-17-006154 · edgar.xml · derivative · entry 1 VANCE DOLLY · CIK 0001237676 · EVP Corp. Affairs, G.C., Sect. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,500 Underlying: Common Stock · 62,500 shares Expires 2024-02-27 F1 · derivative.exercise_date: On February 27, 2014 the reporting person was granted an option to purchase 125,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. As previously reported on April 4, 2016, the Compensation Committee determined that the performance condition had been achieved with respect to 62,500 shares of common stock. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved with respect to the remaining 62,500 shares of common stock, resulting in full vesting of the option. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:47 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $2.74 | $0.00 |
DisclosureSEC source: 0001179110-17-006152 · edgar.xml · derivative · entry 2 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2026-01-26 F2 · derivative.exercise_date: On January 26, 2016 the reporting person was granted an option to purchase 400,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option. Read SEC document |
| April 19, 2017 Filed Apr 21, 2017 21:47 UTC |
RODRIGUEZ RAUL RDirector · CEO, President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001179110-17-006152 · edgar.xml · derivative · entry 1 RODRIGUEZ RAUL R · CIK 0001190279 · Director · CEO, President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2024-02-27 F1 · derivative.exercise_date: On February 27, 2014 the reporting person was granted an option to purchase 150,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. As previously reported on April 4, 2016, the Compensation Committee determined that the performance condition had been achieved with respect to 75,000 shares of common stock. On April 19, 2017, the Compensation Committee determined that the performance conditions had been achieved with respect to the remaining 75,000 shares of common stock, resulting in full vesting of the option. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.